John Sevior on why businesses aren't investing (it's not interest rates)

James Marlay

Livewire Markets

Soft business capex data surprised the market yesterday with a chorus of commentators suggesting further rates cuts are now likely. John Sevior, Portfolio Manager at Airlie Funds, has shared his insights into what he believes is holding back expenditure from Australian companies. “The forces of destruction are at the strongest as they have ever been.” Sevior cites recent comments from Wesfarmers CEO Richard Goyder who says agile digital competitors and reduced barriers to entry are now making the risk reward proposition unacceptable. “we are happy to invest where the spread of possibilities is bad to okay’, but now for a whole range of factors it turns [out] that businesses can be destroyed by digital competitors, access to markets – the barriers to market access have become lower – and he said the spread now has gone from ‘bad to okay’ to ‘very good to disastrous.’ Click here to access the full article via The Insto Report (VIEW LINK)


1 topic

James Marlay
Co Founder
Livewire Markets

Livewire is Australia’s #1 website for expert investment analysis. We work with leading investment professionals to deliver curated content that helps investors make confident and informed decisions. Safe investing and thanks for reading Livewire.

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.

Comments

Sign In or Join Free to comment